Abeona Therapeutics Inc (ABEO)

Etorro trading 970x250
Abeona Therapeutics Inc (ABEO) Logo

About Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York. Address: 1330 Avenue of the Americas, New York, NY, United States, 10019

Abeona Therapeutics Inc News and around…

Latest news about Abeona Therapeutics Inc (ABEO) common stock and company :

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
21 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends ...

Abeona Therapeutics to Present at Jefferies Gene Therapy/Editing Summit
21 Oct, 2021 Yahoo! Finance

NEW YORK and CLEVELAND, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Vish Seshadri, Ph.D., M.B.A., Chief Executive Officer of Abeona, is scheduled to present at the Jefferies Gene Therapy/Editing Summit on Wednesday, October 27, 2021, at 3:30 p.m. ET. A live and archived webcast of the presentation will be available on the investor section of the Abeona Therapeutics website at www.abeonatherape

Abeona Therapeutics (NASDAQ:ABEO) investors are sitting on a loss of 90% if they invested three years ago
21 Oct, 2021 Yahoo! Finance

It's not possible to invest over long periods without making some bad investments. But really bad investments should be...

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
18 Oct, 2021 FinancialContent

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market ...

10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts
17 Oct, 2021 FinancialContent
Abeona Therapeutics Announces Clinical Data Presentations at Upcoming Scientific Congresses
13 Oct, 2021 Yahoo! Finance

NEW YORK and CLEVELAND, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced two presentations of previously disclosed clinical data at upcoming scientific congresses in October 2021. The presentations include a poster presentation on the long-term wound healing and pain relief data from the Phase 1/2a EB-101 trial at the 2021 Pediatric Dermatology Research Alliance (PeDRA) Annual Conference, held virtually

Abeona Therapeutics Appoints Gene Therapy Quality Leader Jon Voss as Vice President, Head of Quality
12 Oct, 2021 Yahoo! Finance

NEW YORK and CLEVELAND, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Jon Voss as Vice President, Head of Quality. Mr. Voss, who has been advising the Company as a consultant, will now serve in a leadership role to further strengthen Abeona’s quality system and oversee all quality functions. “Jon is a proven technical leader with a strong track record of successful quality oversigh

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
05 Oct, 2021 FinancialContent

Gainers Synaptogenix (NASDAQ:SNPX) stock increased by 19.72% to $10.5 during Tuesday's regular session. Trading volume for this ...

Tuesday Sector Laggards: Precious Metals, Drugs
05 Oct, 2021 FinancialContent

In trading on Tuesday, precious metals shares were relative laggards, down on the day by about 1.4%. Helping drag down the group were shares of Huadi International Group, down about 13.3% and shares of Alexco Resource off about 3.9% on the day.

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
22 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Abeona Announces New Chairman, Executive Leadership Promotions and Key Talent Additions for Final Push Towards Two Biologics License Application (BLA) Filings
21 Sep, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
17 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Abeona Therapeutics to Present at Upcoming Investor Conferences
07 Sep, 2021 FinancialContent
Abeona Therapeutics Appoints Edward Carr as Chief Financial Officer
10 Aug, 2021 FinancialContent
Abeona Therapeutics Reports Second Quarter Financial Results
28 Jul, 2021 FinancialContent
Abeona Stock Gains As It Concludes Type B Meeting With FDA For MPS IIIA Gene Therapy
28 Jul, 2021 FinancialContent

Abeona Therapeutics Inc(NASDAQ: ABEO)has completed a Type B meeting with the FDAregarding the pivotal trial for its ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
28 Jul, 2021 FinancialContent

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market ...

Abeona Therapeutics Announces Successful Type B Meeting with U.S. FDA for ABO-102 AAV-based Gene Therapy in Sanfilippo Syndrome Type A (MPS IIIA)
28 Jul, 2021 FinancialContent
34 Stocks Moving in Tuesday's Pre-Market Session
27 Jul, 2021 FinancialContent

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced ...

48 Stocks Moving In Monday's Mid-Day Session
26 Jul, 2021 FinancialContent

Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic ...

Abeona Stock Moves Higher After MPS IIIA Gene Therapy Shows Increase In Brain Volume
26 Jul, 2021 FinancialContent

Abeona Therapeutics Inc(NASDAQ: ABEO)announced magnetic resonance imaging (MRI) datafrom the Phase 1/2 Transpher A ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Jul, 2021 FinancialContent

Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The ...

Abeona Therapeutics Announces New MRI Data Showing Increased Brain Volume in Young Patients with Sanfilippo Syndrome Type A (MPS IIIA) After Treatment with ABO-102 Gene Therapy
26 Jul, 2021 FinancialContent

New data from Phase 1/2 Transpher A study presented at 16th International Symposium on MPS and Related Diseases

Abeona Reports Positive Data for Sanfilippo Syndrome Treatment
26 Jul, 2021 Yahoo! Finance

Abeona Therapeutics releases magnetic resonance imaging data from the Phase 1/2 Transpher A clinical study.

Abeona Therapeutics Activates Second Clinical Trial Site in EB-101 Pivotal Phase 3 VIITAL™ Study for Recessive Dystrophic Epidermolysis Bullosa
23 Jul, 2021 FinancialContent
10 Biggest Price Target Changes For Monday
19 Jul, 2021 FinancialContent

Goldman Sachs boosted QUALCOMM Incorporated (NASDAQ: QCOM) price target from $136 to $148. QUALCOMM shares rose 0.6% to $140.50 in ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
15 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, traders! We're taking a look at the biggest pre-market stock movers for Thursday and retail traders are a major influence. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

8 Hot Penny Stocks on Robinhood That You Need to Know About
09 Jul, 2021 FinancialContent
Abeona Unveils Additional Data From Gene Therapy Trial For Rare Connective Tissue Disorder
07 Jul, 2021 FinancialContent

Abeona Therapeutics Inc(NASDAQ: ABEO) hasannounced updated datafrom Phase 1/2a trial for up to six years following ...

Abeona Therapeutics Inc (ABEO) is a NASDAQ Common Stock listed in , ,

970x250